Hemo Organic Fair Value
Hemo Organic fair value. Hemo Organic (HEMORGANIC) average fair value is ₹17.93 across 2 valuation models — P/E Based Valuation, Price-to-Sales Valuation, vs a current market price of ₹20.99 (-14.6%), fair value range ₹7.74–₹28.11.
Fair Value Analysis Export
HEMORGANIC Fair Value vs Current Price — Valuation Summary
HEMORGANIC average fair value, fair value range, price gap and valuation status across 2 models: P/E Based Valuation, Price-to-Sales Valuation. Analyse HEMORGANIC promoter holding to track promoter, FII and institutional holdings.
P/E Based Valuation
Price-to-Sales Valuation
HEMORGANIC Fair Value Analysis — Data Sources & Coverage
Hemo Organic financial data sources, valuation methods applied and sector benchmarks used. For live price and a broader fundamental view, visit Hemo Organic share price screener.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
HEMORGANIC vs Commercial Services Sector Peers — P/E, P/B & Market Cap
Hemo Organic P/E ratio, P/B ratio and market capitalisation vs Commercial Services sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Viksit Engineering | VIKSHEN | - | - | - |
| Yarn Syndicate | YARNPP | - | 0.12 | ₹3 |
| Ardi Investments & Tradi… | ZARDIINV | 1.44 | -40.74 | ₹0 |
| Moving Media Entertainme… | MMEL | 4.36 | 0.55 | ₹45 |
| Quasar | QUASAR | - | 0.14 | ₹14 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.